| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
| 08/05/2004 | CA2648056A1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 08/05/2004 | CA2514153A1 Antibody and use thereof |
| 08/05/2004 | CA2513797A1 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 08/04/2004 | EP1443112A2 Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/04/2004 | EP1443051A2 Sugar modified oligonucleotides that detect and modulate gene expression |
| 08/04/2004 | EP1442295A2 Periostin-based diagnostic assays |
| 08/04/2004 | EP1442135A2 Devices and methods for detecting genetic sequences |
| 08/04/2004 | EP1442128A2 Production, detection and use of transformant cells |
| 08/04/2004 | EP1442121A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 08/04/2004 | EP1442120A2 Alkaline protease variants and detergents and cleansers containing these alkaline protease variants |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442062A2 Methods for the treatment of carcinoma |
| 08/04/2004 | EP1442060A2 A novel g protein-coupled receptor, gave 10 |
| 08/04/2004 | EP1442052A1 High level constitutive production of anthrax protective antigen |
| 08/04/2004 | EP1442046A2 Mammalian c-type lectins |
| 08/04/2004 | EP1441766A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 08/04/2004 | EP1441760A2 Anthrax antigenic compositions |
| 08/04/2004 | EP1441682A1 Method to induce neovascular formation and tissue regeneration |
| 08/04/2004 | EP1384075A4 Methods of detecting early renal disease in animals |
| 08/04/2004 | EP1315826A4 Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| 08/04/2004 | EP0764171B1 Ligands for induction of antigen specific apoptosis in t cells |
| 08/04/2004 | EP0725829B1 Methods and compositions for high protein production from recombinant dna |
| 08/04/2004 | EP0637963B1 Cd28 pathway immunoregulation |
| 08/04/2004 | EP0480949B2 Production of viral vaccine |
| 08/04/2004 | CN1518598A Serpin in Bifidobacteria |
| 08/04/2004 | CN1518559A VHH single heavy chain antibody and method for its preparation in mammal |
| 08/04/2004 | CN1517362A New Polypeptide-human ribosome protein s9 containing ATP/GTP conjugated structure domain and polynucleotide coding said polypetide |
| 08/04/2004 | CN1160465C Funguns wherein areA, pepC and/or pepE genes have been inactivated |
| 08/04/2004 | CN1160462C Use of gram-positive bacteria to express recombinant proteins |
| 08/04/2004 | CN1160457C Recombinant mistletoe lectin (rML) |
| 08/04/2004 | CN1160448C Prokaryotic cell comprising two copies of gene transcribed in different directions |
| 08/04/2004 | CN1160369C Preparation of anti cytoplasmic thymidine kinase-IgY antibody and tumor diagnosis composition |
| 08/03/2004 | US6770743 Genetic engineered drug |
| 08/03/2004 | US6770631 Non-identical genes and their application in improved molecular adjuvants |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770461 High bone mass gene of 11q13.3 |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770455 Preparation, use and medicaments containing ribonucleotide polypeptides or their molecular-biological equivalent structures and/or parts and/or derivatives |
| 08/03/2004 | US6770450 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 08/03/2004 | US6770282 Purified nucleic acid molecule encoding rabies glycoprotein g, complexed with a cationic lipid comprising tetramethyltetraalkyl spermine analog lipid; enhances immune response compared to administration of a naked dna vaccine |
| 08/03/2004 | CA2144317C Hepatitis a virus vaccines |
| 08/03/2004 | CA2142599C Method for diagnosing and monitoring sepsis |
| 08/03/2004 | CA2089111C Smooth muscle mitogen and isolated dna coding therefor |
| 07/29/2004 | WO2004063714A2 Methods for the detection, analysis and isolation of nascent proteins |
| 07/29/2004 | WO2004063370A1 Process for producing glycoprotein having animal type sugar chain |
| 07/29/2004 | WO2004063346A2 Lysozyme transgenic ungulates |
| 07/29/2004 | WO2004063024A2 Floral packaging material having prints thereon |
| 07/29/2004 | WO2004062619A2 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 07/29/2004 | WO2004044156A3 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 07/29/2004 | WO2004039963A8 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof |
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2003099853A3 Petide amidation process |
| 07/29/2004 | WO2003068915A3 Production of human antibodies in immunodeficient, non-human, mammalian hosts |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003066664A3 Complex technologies using enzymatic protein hydrolysate |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003054155A3 Pichia pastoris formate dehydrogenase and uses therefor |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | US20040148646 Animals comprising human hepatocellular tissue |
| 07/29/2004 | US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor |
| 07/29/2004 | US20040147733 for diagnosis/therapy for immune system-related disorders; drug screening; genetic engineering |
| 07/29/2004 | US20040147725 for cancer treatment by inducing apoptosis; monoclonal antibodies; genetic engineering; kits |
| 07/29/2004 | US20040147723 Moringa seed proteins |
| 07/29/2004 | US20040147718 Nucleotide and protein sequences of lats genes and methods based thereon |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147437 Calycins |
| 07/29/2004 | US20040147017 for pharmaceuticals, diagnostics, biosensors and bioreactors; thrombolytic agents, interferons, interleukins, erythropoietins, colony stimulating factors, and cytokines; solid phase synthesis |
| 07/29/2004 | US20040147014 Chemical reaction circuit for cell-free protein synthesis |
| 07/29/2004 | US20040147011 High growth methanotrophic bacterial strain |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146991 Identifying modulator of activation inducible lymphocyte immunomodulatory molecule (AILIM) for use in suppressing, preventing and/or treating inflammatory, autoimmune and allergic disorders |
| 07/29/2004 | US20040146990 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146987 Nucleotide sequences coding chloramphenicol acetyltransferase, luciferase, beta-glucuronidase or beta-galactosidase gnetically engineered fusion polypeptide with reduced half-life of expression; diagnostic tools for genetic and disease analysis |
| 07/29/2004 | US20040146985 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 07/29/2004 | US20040146983 Enhanced production of Streptococcus mutans mutacin I and III |
| 07/29/2004 | US20040146980 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof |
| 07/29/2004 | US20040146972 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/29/2004 | US20040146969 Process for producing recombinant protein and fused protein |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146914 comprising bromodomains and the encoding gene; for anticancer agents; genetic engineering |
| 07/29/2004 | US20040146908 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 07/29/2004 | US20040146892 Expression vector coding organelle transport protein for use in identifying modulators of adenine nucleotide translocator and cyclophilin d interaction |
| 07/29/2004 | US20040146889 Inducible regulatory system and use thereof |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146533 Useful for vaccinating |
| 07/29/2004 | US20040146525 Shellfish protein |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | DE10045016B4 Retrovirale Vektoren mit Fremdsequenzinsertion zwischen retroviraler Primerbindungsstelle und retroviralem Spleißdonor Retroviral vectors with Fremdsequenzinsertion between retroviral primer binding site and retroviral splice donor |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/29/2004 | CA2512552A1 Methods for the detection, analysis and isolation of nascent proteins |
| 07/28/2004 | EP1441030A1 Method of purifying recombinant fused protein and method of producing protein using the same |
| 07/28/2004 | EP1440982A2 Ifn-thy fusion protein, dna coding therefore, its preparation and application |